Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAF1 | P04049 | 4/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6168156 | 0.88 | EPHX2 (0.41) | EPHX2EPHX1HTTALDH1A1POLB | |
| SCHEMBL6168479 | 0.87 | EPHX2 (0.40) | EPHX2EPHX1HTTALDH1A1POLB | |
| SCHEMBL6172128 | 0.81 | EPHX2 (0.41) | EPHX2EPHX1HTTALDH1A1POLB | |
| SCHEMBL6169782 | 0.79 | EPHX2 (0.40) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL6169959 | 0.79 | MAPT (0.46) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL6169054 | 0.78 | MAPK14 (0.61) | RAF1MAPK14 | |
| SCHEMBL6168671 | 0.76 | ALDH1A1 (0.45) | MAPTEPHX2EPHX1HTTALDH1A1 | |
| SCHEMBL6170836 | 0.75 | MAPT (0.44) | MAPTRAF1EPHX2EPHX1HTT | |
| SCHEMBL14159740 | 0.71 | CYP1A2 (0.45) | MAPTRAF1ALDH1A1POLBMAPK14 | |
| SCHEMBL3264762 | 0.70 | KDM4E (0.46) | MAPTALDH1A1POLBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1163236-B1 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS | BOEHRINGER INGELHEIM PHARMA (US) | 2005-11-09 | — | — | EP | disclosed |
| US-6476023-B1 | Aromatic heterocyclic compounds as anti-inflammatory agents | BOEHRINGEN INGELHEIM PHARMACEUTICALS, INC. | 2002-11-05 | — | — | US | disclosed |
| US-6297381-B1 | INHIBIT THE RELEASE OF INFLAMMATORY CYTOKINES SUCH AS INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, UREAS OR THIOUREAS SUBSTITUTED BY A PYRROLE OR THIOPHENE | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2001-10-02 | — | — | US | disclosed |